CBDX (Curative Biosciences) Net Margin %: 0.00% (As of Mar. 2018)


What is Curative Biosciences Net Margin %?

Curative Biosciences CBDX Net Margin % is 0.00% as of Mar. 2018.

Net margin is calculated as Net Income divided by its Revenue. Curative Biosciences's Net Income for the three months ended in Mar. 2018 was $-0.03 Mil. Curative Biosciences's Revenue for the three months ended in Mar. 2018 was $0.00 Mil. Therefore, Curative Biosciences's net margin for the quarter that ended in Mar. 2018 was 0.00%.

The historical rank and industry rank for Curative Biosciences's Net Margin % or its related term are showing as below:


CBDX's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.695
* Ranked among companies with meaningful Net Margin % only.

Curative Biosciences  (OTCPK:CBDX) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Curative Biosciences Net Margin % Related Terms

Curative Biosciences Net Margin % Historical Data

* Premium members only.

The historical data trend for Curative Biosciences's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curative Biosciences Net Margin % Chart

Curative Biosciences Annual Data
Trend Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4,097.53 0.00 0.00 0.00 0.00

Curative Biosciences Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CBDX vs ACUR, CVLB, RDGL: Net Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Curative Biosciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curative Biosciences Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curative Biosciences's Net Margin % distribution charts can be found below:

* The bar in red indicates where Curative Biosciences's Net Margin % falls into.


Curative Biosciences Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Curative Biosciences's Net Margin for the fiscal year that ended in Jun. 2017 is calculated as

Net Margin=Net Income (A: Jun. 2017 )/Revenue (A: Jun. 2017 )
=-0.053/0
= %

Curative Biosciences's Net Margin for the quarter that ended in Mar. 2018 is calculated as

Net Margin=Net Income (Q: Mar. 2018 )/Revenue (Q: Mar. 2018 )
=-0.032/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Curative Biosciences (CBDX) has a Net Margin % of 0.00% as of Mar. 2018. Net margin is the ratio of total net income to net sales. View historical data on Curative Biosciences and its competitors.
Is Curative Biosciences' Net Margin % too high?
Curative Biosciences' current Net Margin % is 0.00%.
How does Curative Biosciences' Net Margin % compare to ACUR and CVLB?
Curative Biosciences' Net Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median Net Margin % is 5.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.70, based on 954 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Curative Biosciences and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Curative Biosciences's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curative Biosciences stock overvalued right now?
Curative Biosciences (CBDX) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Curative Biosciences (CBDX), the current Net Margin % is 0.00% as of Mar. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curative Biosciences Business Description

Address 2 South Biscayne Boulevard, Suite 3760, Miami, FL, USA, 33131
Curative Biosciences Inc is a life sciences company focused on developing and commercializing novel therapeutics using hemp-derived CBD. Its products comprise of CBD softgels, Hemp oil, and Topicals.